Project Grant R01AI189411
Award Date
11/13/24
Completion Date
10/31/29
Dollars Obligated
$715K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $220,224 to the University of Chicago for computational investigations of HIV-1 assembly, maturation, and uncoating processes. The research aims to advance the mechanistic understanding of these critical viral life cycle stages, which could aid in the design of future antiretroviral therapies that disrupt these...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $997,318.00 to Northwestern University to evaluate whether vaccine fractionation can improve the immunogenicity of HIV vaccines in mice and macaques. The research aims to determine if priming with a low vaccine dose followed by boosting with a standard dose can result in more potent immune responses compared to...
This federal Project Grant award of $696,828, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the structural basis of HIV-1 cap hypermethylation and its linkage to viral post-transcriptional control and modulation of host innate immune signaling. Key objectives include elucidating the role of the HIV-1 Rev/RRE regulatory system in cap hypermethylation, and how...
This $856,202 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a study of the role of IL-10 and IFN signaling in achieving HIV functional cure. The research aims to determine if enhancing the activity of interleukin-10 (IL-10) and type I interferons (IFNs) could be a potential strategy for HIV functional cure. The project will leverage a unique cohort of people with HIV...
This federal Project Grant award, totaling $285,816.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The objective of this 3-year project, with a start date of September 12, 2024, is to investigate the role of ADP-ribosylation (ADPR) and its associated proteins in modulating HIV-1 latency and reactivation. The research aims to identify global proteomic changes to ADPR during HIV-1...
This federal Project Grant award, totaling $131,268, was made by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports research at George Washington University to assess the role of the phosphatases PTPN1 and PTPN2 in controlling the activation and expression of cytotoxic proteins in natural killer (NK) cells. The research aims to enhance the cytolytic activity of NK cells against...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to investigate the in vivo mechanisms of the innate immune response to HIV-1 infection. The award, totaling $231,752.00, will be provided to the Fred Hutchinson Cancer Center in Seattle, WA from August 1, 2024 through June 30, 2026. The research aims to identify the cellular sources of...
This federal Project Grant award, valued at $7,105,240.00 and awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support the development of an HIV vaccine regimen that elicits both broadly neutralizing antibodies and high-quality T-cell responses. The research program will examine cooperative antibody and T-cell responses in humans, leverage IL-10 inhibitors to safely elicit high-quality CD8+...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to better understand the molecular mechanisms of HIV spread through cell-cell contact across a virological synapse (VS). The $515,282 award will enable Case Western Reserve University (CWRU) to develop a novel flow cytometry assay for quantifying and purifying infected cell-target cell pairs, and leverage...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $617,376 to Emory University to conduct research on the activation and maturation of the HIV-1 protease enzyme. The objective is to elucidate the timing and regulation of protease autoactivation, which is critical for the formation of mature, infectious HIV-1 particles. The research will utilize advanced imaging...